Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626132 · ClinicalTrials.gov registry record · Phase 2
Standardized Eucommia Extract in the Treatment of Hypertension
A Phase 2 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00626132 is a Phase 2 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 30 participants.
The verdict
NCT00626132, a Phase 2 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that eucommia, an herb used in China for making tea, is safe and effective for lowering blood pressure in humans with high blood pressure.
Interventions
- DIETARY_SUPPLEMENT Eucommia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-05 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00626132
The ClinicalTrials.gov registry entry for NCT00626132 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eucommia is the first listed.
NCT00626132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00626132 about?
NCT00626132 is a clinical study titled "Standardized Eucommia Extract in the Treatment of Hypertension". The purpose of this study is to demonstrate that eucommia, an herb used in China for making tea, is safe and effective for lowering blood pressure in humans with high blood pressure.
What is the current status of trial NCT00626132?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2007-05. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00626132?
The interventions under investigation include: Eucommia (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00626132?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.